1. Home
  2. IMCC vs RDHL Comparison

IMCC vs RDHL Comparison

Compare IMCC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • RDHL
  • Stock Information
  • Founded
  • IMCC 1980
  • RDHL 2009
  • Country
  • IMCC Israel
  • RDHL Israel
  • Employees
  • IMCC N/A
  • RDHL N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMCC Health Care
  • RDHL Health Care
  • Exchange
  • IMCC Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • IMCC 7.5M
  • RDHL 8.2M
  • IPO Year
  • IMCC N/A
  • RDHL N/A
  • Fundamental
  • Price
  • IMCC $2.37
  • RDHL $5.85
  • Analyst Decision
  • IMCC
  • RDHL
  • Analyst Count
  • IMCC 0
  • RDHL 0
  • Target Price
  • IMCC N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • IMCC 17.6K
  • RDHL 11.0K
  • Earning Date
  • IMCC 03-27-2025
  • RDHL 08-29-2024
  • Dividend Yield
  • IMCC N/A
  • RDHL N/A
  • EPS Growth
  • IMCC N/A
  • RDHL N/A
  • EPS
  • IMCC N/A
  • RDHL N/A
  • Revenue
  • IMCC $38,042,859.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • IMCC $22.59
  • RDHL $224.90
  • Revenue Next Year
  • IMCC $32.86
  • RDHL $82.69
  • P/E Ratio
  • IMCC N/A
  • RDHL N/A
  • Revenue Growth
  • IMCC N/A
  • RDHL N/A
  • 52 Week Low
  • IMCC $1.44
  • RDHL $5.41
  • 52 Week High
  • IMCC $8.10
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 53.35
  • RDHL 40.41
  • Support Level
  • IMCC $2.05
  • RDHL $5.80
  • Resistance Level
  • IMCC $2.60
  • RDHL $6.26
  • Average True Range (ATR)
  • IMCC 0.21
  • RDHL 0.31
  • MACD
  • IMCC 0.02
  • RDHL 0.01
  • Stochastic Oscillator
  • IMCC 58.31
  • RDHL 19.33

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: